Cargando…
Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial
Objective: Glutamate is considered a target for treating obsessive-compulsive disorder (OCD). The efficacy and safety of the nutritional supplement of N-Acetylcysteine (NAC) as an adjuvant to serotonin reuptake inhibitor (SSRI) for treating children and adolescents with OCD has never been examined....
Autores principales: | Ghanizadeh, Ahmad, Mohammadi, Mohammad Reza, Bahraini, Shahla, Keshavarzi, Zahra, Firoozabadi, Ali, Alavi Shoshtari, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Psychiatry & Psychology Research Center, Tehran University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483239/ https://www.ncbi.nlm.nih.gov/pubmed/28659986 |
Ejemplares similares
-
Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
por: Afshar, Hamid, et al.
Publicado: (2014) -
Prevalence of obsessive-compulsive disorder in Iran
por: Mohammadi, Mohammad Reza, et al.
Publicado: (2004) -
The Role of N-Acetylcysteine in Obsessive-Compulsive (OCD) and Related Disorders
por: Sá Couto, J., et al.
Publicado: (2022) -
The Effect of Atorvastatin on Obsessive-compulsive Symptoms of Refractory Obsessive-compulsive Disorder (Add-on Therapy)
por: Akouchekian, Shahla, et al.
Publicado: (2018) -
Antipsychotic augmentation in the treatment of obsessive-compulsive disorder
por: Thamby, Abel, et al.
Publicado: (2019)